ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Down 70.9% in November

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the recipient of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 23,800 shares, a decrease of 70.9% from the November 15th total of 81,700 shares. Based on an average daily volume of 228,800 shares, the days-to-cover ratio is presently 0.1 days. Currently, 3.6% of the shares of the company are short sold.

ReShape Lifesciences Stock Down 4.2 %

RSLS stock traded down $0.21 during midday trading on Wednesday, reaching $4.83. 44,098 shares of the company’s stock traded hands, compared to its average volume of 96,788. The stock’s 50-day moving average is $5.48 and its 200 day moving average is $8.88. ReShape Lifesciences has a 52-week low of $4.48 and a 52-week high of $34.22.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.